Clinical trial
Doxazosin an a1 Antagonist for Alcohol Dependence
NCT01437046 is registered in ClinicalTrials.gov with Brown University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Doxazosin an a1 Antagonist for Alcohol Dependence
- Lead sponsor
- Brown University
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- November 1, 2011
- Completion date
- March 1, 2015
- Enrollment
- 41 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
alcohol dependence, anxiety